Fallen Angels
active
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.
Bain Capital Healthcare
We have built one of the largest and deepest healthcare investing teams in the world. Click here to read more about the breadth and legacy of our efforts.
© 2012-2025 Bain Capital, LP. The Bain Capital square symbol is a trademark of Bain Capital, LP. All Rights Reserved.
Log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com
© 2012-2025 Bain Capital, LP. The Bain Capital square symbol is a trademark of Bain Capital, LP. All Rights Reserved.